No headlines found.
No press releases found.
No news found.
Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare. The Fund invests at least 80% of its total assets, plus borrowings for investment purposes (if any), in the securities of the Global X HealthTech Index (the "Underlying Index") and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the Underlying Index. The objective of the Global X HealthTech Index is to track the performance of companies involved in Healthcare Technology industry.
Global X Healthtech ETF trades on the NASDAQ stock market under the symbol HEAL.
As of September 8, 2026, HEAL stock price declined to $29.36 with 782 million shares trading.
HEAL has a market cap of $30.82 million. This is considered a Sub-Micro Cap stock.
HEAL has underperformed the market in the last year with a price return of -7.3% while the SPY ETF gained +19.5%. However, in the short term, HEAL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +15.3% vs +1.7% return in SPY. But in the last 2 weeks, HEAL shares have been beat by the market, returning -3.8% compared to an SPY return of +0.3%.
HEAL support price is $29.15 and resistance is $30.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HEAL shares will trade within this expected range on the day.
